Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Annals of Neurology|March 9, 2018
Inflammatory intrathecal profiles and cortical damage in multiple sclerosisRoberta Magliozzi, Owain W Howell, Richard Nicholas, et al.Annals of Neurology|May 18, 2020
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis ActivityRoberta Magliozzi, Antonio Scalfari, Anna Isabella Pisani, et al.Journal of Neurology|November 24, 2016
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosisLuca Prosperini, Francesco Saccà, Cinzia Cordioli, et al.Eclinicalmedicine|August 25, 2020
Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-upNicola De Rossi, Cristina Scarpazza, Chiara Filippini, et al.Immunologic Research|May 12, 2023
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative studyCecilia Zivelonghi, Alessandro Dinoto, Sarosh R Irani, et al.Neuroscience Letters|October 17, 2012
Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern EuropeansPaola Brambilla, Federica Esposito, Eva Lindstrom, et al.Frontiers in Behavioral Neuroscience|March 5, 2016
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical TrialFlavia Mattioli, Fabio Bellomi, Chiara Stampatori, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2012
A genome-wide association study in progressive multiple sclerosisFilippo Martinelli-Boneschi, Federica Esposito, Paola Brambilla, et al.Journal of Neuroimmunology|August 14, 2023
Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumabAlessandra Sottini, Virginia Quaresima, Mosè Barbaro, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 14, 2019
Impact of natural menopause on multiple sclerosis: a multicentre studyDamiano Baroncini, Pietro Osvaldo Annovazzi, Nicola De Rossi, et al.Pageof 9